Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8507658
APP PUB NO 20120107342A1
SERIAL NO

13373428

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are antibodies specifically directed against a cathepsin-like protease that are specific for newly excysted juvenile (NEJ) stages of Fasciola hepatica. Diagnostic tests wherein such antibodies are detected or used are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STICHTING WAGENINGEN RESEARCHDROEVENDAALSESTEEG 4 WAGENINGEN 6708 PB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bokhout, Bernard Adri Ermelo, NL 5 8
Cornelissen, Johannes Bernardus Wilhelmus Joseph Dronten, NL 5 8
van, Milligen Florine Johanna Abcoude, NL 5 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 13, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00